 | Viking Therapeutics, Inc. | |||
| NCM : VKTX || Location: United States | ||||
$68.86+3.79 (+5.82%) |
3.52 M | 62.56 - 69.17 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 11.148 M |
| March 28, 2024 | 9.522 M |
| March 15, 2024 | 11.142 M |
| Feb. 29, 2024 | 12.277 M |
| Feb. 15, 2024 | 12.020 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.26 | -0.25 | 3.25% |
| 09/30/2023 | -0.22 | -0.23 | -2.91% |
| 06/30/2023 | -0.20 | -0.19 | 3.16% |
| 03/31/2023 | -0.24 | -0.25 | -2.12% |
| 12/31/2022 | -0.24 | -0.26 | -9.98% |
VKTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 110.218M | Shares Float | 104.258M |
| Short Float | 11.148M | Market Cap | 7171.89M |
| Institution ownership | 71.64% | Insider ownership | 6.035% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -0.91 | Forward EPS | -1.52 |